Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Transformed migraine--chronic daily headache].

M G Bøe1, P Monstad

  • 1Nevrologisk avdeling Vest-Agder Sentralsykehus, Kristiansand. magne.boe@c2i.net

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|February 10, 2000
PubMed
Summary

Transformed migraine, a common cause of chronic daily headache, benefits from diagnostic labeling. While dihydroergotamine (DHE) offers short-term relief, medication withdrawal and patient support are crucial for long-term management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Organizational changes aiming to reduce iv tPA door-to-needle time.

Acta neurologica Scandinavica·2013
Same author

Chronic daily headache with medication overuse: predictors of outcome 1 year after withdrawal therapy.

European journal of neurology·2009
Same author

Chronic daily headache with medication overuse: a randomized follow-up by neurologist or PCP.

Cephalalgia : an international journal of headache·2009
Same author

Microvascular decompression as a treatment for cranial nerve hyperactive dysfunction--a critical view.

Acta neurologica Scandinavica. Supplementum·2007
Same author

Absence of focal neurological involvement in tick-borne relapsing fever in northern Tanzania.

European journal of neurology·2005
Same author

Onset and course of chronic inflammatory demyelinating polyneuropathy.

Muscle & nerve·2005

Area of Science:

  • Neurology
  • Headache Medicine

Context:

  • Chronic daily headache (CDH) is a significant clinical challenge.
  • The International Headache Society classification system does not address the long-term evolution of headache disorders.
  • Transformed migraine is increasingly recognized as a prevalent cause of CDH.

Purpose:

  • To advocate for the diagnostic label 'transformed migraine' in patients with CDH and migrainous features.
  • To evaluate the efficacy of intravenous dihydroergotamine (DHE) as an acute treatment for transformed migraine.
  • To emphasize the importance of non-pharmacological interventions in managing CDH.

Summary:

  • The study supports using 'transformed migraine' as a diagnostic label for CDH with migrainous features and a history of migraine.
  • Intravenous dihydroergotamine (DHE) was administered to 16 patients with CDH; 10 reported immediate relief, but only four had sustained relief beyond two weeks.

Related Experiment Videos

  • The authors highlight medication withdrawal, patient education, and support as primary therapeutic strategies, with DHE potentially aiding the withdrawal process.

    • Impact:

    • This research encourages a more patient-centered diagnostic approach to chronic daily headache.
    • It underscores the limitations of solely relying on acute pharmacological interventions like DHE for transformed migraine.
    • The findings emphasize the critical role of comprehensive management strategies, including behavioral support, for improving long-term outcomes in transformed migraine patients.